Gram positive infection in trauma patients: New strategies to decrease emerging Gram-positive resistance and vancomycin toxicity

International Journal of Antimicrobial Agents

Volumn 16, Issue SUPPL. 1, 2000, Pages 39-42

  Ginzburg, Enrique ^a   Namias, Nicholas ^a   Brown, Margaret ^a   Ball, Suzette ^a   Hameed, Syed M ^a   Cohn, Stephen M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Gram positive; Staphylococcus aureus; Trauma patients

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; METICILLIN; MINOCYCLINE; OXACILLIN; RIFAMPICIN; SULFANILAMIDE DERIVATIVE; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; CONFERENCE PAPER; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION CONTROL; INJURY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL;

EID: 0034532143     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0924-8579(00)00305-8     Document Type: Conference Paper

References (15)

1. Data summary from January 1990-May 1999, issued June 1999
2. Incidence of oral glycopeptides on the fecal flora of human volunteers, selection of highly glycopeptide resistant enterococci
3. Issues for debate in critical care, restriction of third generation cephalosponin use
4. A multicenter economic analysis of bacteremia caused by methicillin-resistant Staphylococcus aureus
5. The economic impact of bacteremia due to vancomycin-resistant Enterococcusfaecium: A case control study
6. Report of the ASM Task force on antibiotic resistance
7. Long-term use of vancomycin has resulted in vancomycin resistant Staphylococcus aureus
8. MRSA: Winning battles, but who'll win the war?
9. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
10. In vitro susceptibility patterns of methicillin-resistant and susceptible Staphylococcus aureus strains in a population of parenteral drug abusers from 1972 to 1981
11. Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections
12. In-vitro susceptibility of isolates of methicillin-resistant Staphylococcus aureus 1988-1993
13. Staphylococcus aureus infection
14. Prospective randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheterrelated staphylococcal bacteremia
15. Antimicrobial activity of quinupristin/dalfopristin (RP 59500, Synercid®) tested against over 28 000 recent clinical isolates from 200 medical centers in the United States and Canada